Michel Doumith
- Molecular Medicine top 0.02%
- Antibiotic Resistance in Bacteria 77
- Endocrinology top 0.1%
- Vibrio bacteria research studies 20
- Enterobacteriaceae and Cronobacter Research 17
- Infections and bacterial resistance 14
- Biotechnology top 0.1%
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 19
-
- Antibiotics Pharmacokinetics and Efficacy 16
-
- Pharmaceutical and Antibiotic Environmental Impacts 15
-
- Salmonella and Campylobacter epidemiology 14
- Co-authors
- Neil WoodfordDavid M. LivermoreChristine JacquetMatthew J. EllingtonPaul MartinCarmen BuchrieserPhilippe GlaserKatie L. Hopkins
- Journals
- Journal of Antimicrobial Chemotherapy (37 papers)International Journal of Antimicrobial Agents (6 papers)Journal of Infection and Public Health (6 papers)
- Partner nations
- United KingdomSaudi ArabiaFrance
In The Last Decade
Michel Doumith
116 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Medicine 4.7k
- Endocrinology 2.2k
- Applied Microbiology and Biotechnology 598
- Biotechnology 1.5k
- Clinical Biochemistry 886
Countries citing papers authored by Michel Doumith
This map shows the geographic impact of Michel Doumith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Doumith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Doumith more than expected).
Fields of papers citing papers by Michel Doumith
This network shows the impact of papers produced by Michel Doumith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Doumith. The network helps show where Michel Doumith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michel Doumith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2020 | 23 | |
| 4 | 2018 | 120 | |
| 5 | 2017 | 59 | |
| 6 | 2017 | 143 | |
| 7 | 2017 | 22 | |
| 8 | 2017 | 58 | |
| 9 | 2016 | 16 | |
| 10 | 2016 | 48 | |
| 11 | 2016 | 221 | |
| 12 | 2016 | 212 | |
| 13 | 2015 | 25 | |
| 14 | 2014 | 27 | |
| 15 | 2010 | 51 | |
| 16 | 2010 | 74 | |
| 17 | 2010 | 122 | |
| 18 | 2010 | 90 | |
| 19 | 2008 | 41 | |
| 20 | 1997 | 29 |
About Michel Doumith
Michel Doumith is a scholar working on Molecular Medicine, Endocrinology, Clinical Biochemistry, Applied Microbiology and Biotechnology and Pollution, having authored 117 papers that have together received 7.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (77 papers), Vibrio bacteria research studies (20 papers), Bacterial Identification and Susceptibility Testing (19 papers), Enterobacteriaceae and Cronobacter Research (17 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmaceutical and Antibiotic Environmental Impacts (15 papers), Salmonella and Campylobacter epidemiology (14 papers) and Infections and bacterial resistance (14 papers). The work is most often cited by research in Molecular Medicine (4.7k citations), Endocrinology (2.2k citations), Applied Microbiology and Biotechnology (598 citations), Biotechnology (1.5k citations) and Clinical Biochemistry (886 citations). Michel Doumith has collaborated with scholars based in United Kingdom, Saudi Arabia and France. Frequent co-authors include Neil Woodford, David M. Livermore, Christine Jacquet, Matthew J. Ellington, Paul Martin, Carmen Buchrieser, Philippe Glaser, Katie L. Hopkins, Shazad Mushtaq and Russell Hope. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Journal of Infection and Public Health, Antimicrobial Agents and Chemotherapy and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.